Seven Fleet Capital Management LP
CIK
2092021
Location
MOUNTAIN VIEW, CA
Portfolio Value
Small
$609,560,652
Diversification
Diversified
Reports for
DV Trading LLC
Filing Date
Global Rank
#2,547
/ 8,700
▲ 3941
Top Industry
Biotechnology
96.0%
Period ended 2 months ago
Filed Aug 17, 2026 · 27d
3 quarters · since Dec 2025
Portfolio Concentration
95 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
22.0%
+15.8 pts
Top 5
53.7%
+30.3 pts
Top 10
65.6%
+24.5 pts
HHI
904
Diversified+648
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $609,560,652 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | +2,726,132 | 3,228,144 | $100,911,781 | |
| CGON | CG Oncology, Inc. | +1,810,478 | 1,886,236 | $134,017,067 | |
| IPSC | Century Therapeutics, Inc. | +1,400,000 | 4,347,826 | $10,652,173 | |
| TSHA | Taysha Gene Therapies, Inc. | +878,692 | 1,504,400 | $10,244,964 | |
| NERV | Minerva Neurosciences, Inc. | +752,897 | 1,001,373 | $5,557,619 | |
| CTMX | CytomX Therapeutics, Inc. | +714,000 | 1,085,398 | $4,070,242 | |
| SABS | SAB Biotherapeutics, Inc. | +636,077 | 736,077 | $2,870,700 | |
| GERN | Geron Corp | +633,048 | 1,057,228 | $1,353,251 | |
| PHVS | Pharvaris N.V. | +601,770 | 774,501 | $26,782,243 | |
| AVTX | Avalo Therapeutics, Inc. | +556,946 | 770,765 | $14,243,736 | |
| ASMB | Assembly Biosciences, Inc. | +377,000 | 433,147 | $11,902,879 | |
| CCCC | C4 Therapeutics, Inc. | +324,093 | 381,169 | $1,780,059 | |
| XNCR | Xencor Inc | +288,305 | 368,305 | $5,929,710 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | +207,600 | 317,600 | $1,540,360 | |
| ELVN | Enliven Therapeutics, Inc. | +201,356 | 365,386 | $18,543,339 | |
| AVBP | ArriVent BioPharma, Inc. | +196,354 | 246,606 | $8,567,092 | |
| DMRA | Damora Therapeutics, Inc. | +183,182 | 284,430 | $7,398,024 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | +177,270 | 610,785 | $4,037,288 | |
| RVMD | Revolution Medicines, Inc. | +161,237 | 242,029 | $45,327,190 | |
| VYGR | Voyager Therapeutics, Inc. | +115,203 | 230,406 | $806,421 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +97,267 | 117,067 | $7,368,196 | |
| ROIV | Roivant Sciences Ltd. | +91,958 | 220,126 | $7,790,259 | |
| ERAS | Erasca, Inc. | +85,539 | 308,007 | $5,642,687 | |
| LQDA | Liquidia Corp | +68,727 | 256,603 | $20,458,957 | |
| ABVX | Abivax S.A. | +68,282 | 111,334 | $14,836,368 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −283,906 | 233,066 | $510,414 | |
| AGIO | Agios Pharmaceuticals, Inc. | −152,647 | 56,900 | $2,111,559 | |
| SLN | Silence Therapeutics plc | −96,652 | 60,107 | $659,974 | |
| RLAY | Relay Therapeutics, Inc. | −79,516 | 178,222 | $3,334,533 | |
| PCVX | Vaxcyte, Inc. | −78,650 | 29,800 | $1,732,274 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | −64,255 | 21,432 | $201,032 | |
| MIST | Milestone Pharmaceuticals Inc. | −63,100 | 270,233 | $362,112 | |
| BCRX | Biocryst Pharmaceuticals Inc | −51,469 | 51,024 | $510,240 | |
| IDYA | IDEAYA Biosciences, Inc. | −48,418 | 37,865 | $1,411,228 | |
| CATX | Perspective Therapeutics, Inc. | −46,469 | 332,613 | $1,134,210 | |
| LPCN | Lipocine Inc. | −46,100 | 78,842 | $201,835 | |
| LRMR | Larimar Therapeutics, Inc. | −25,664 | 230,921 | $704,309 | |
| FULC | Fulcrum Therapeutics, Inc. | −20,011 | 18,089 | $66,205 | |
| ENTX | Entera Bio Ltd. | −14,188 | 191,354 | $338,696 | |
| LONA | LeonaBio, Inc. | −10,523 | 154,153 | $1,416,666 | |
| PMVP | PMV Pharmaceuticals, Inc. | −9,929 | 53,569 | $71,782 | |
| SYRE | Spyre Therapeutics, Inc. | −6,390 | 13,300 | $1,180,774 | |
| GLUE | Monte Rosa Therapeutics, Inc. | −5,730 | 16,800 | $406,560 | |
| KRYS | Krystal Biotech, Inc. | −2,542 | 1,774 | $659,342 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −2,131 | 14,540 | $261,138 | |
| COGT | Cogent Biosciences, Inc. | −1,889 | 147,510 | $5,708,637 | |
| ALKS | Alkermes plc. | −885 | 23,285 | $1,220,134 | |
| ASND | Ascendis Pharma A/S | −310 | 11,869 | $3,165,699 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
22 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | 110,393 | $12,923,708 | |
| MANE | Veradermics, Inc | 80,000 | $9,835,200 | |
| STRO | Sutro Biopharma, Inc. | 159,118 | $5,282,717 | |
| EDIT | Editas Medicine, Inc. | 1,330,500 | $4,310,820 | |
| SGMT | Sagimet Biosciences Inc. | 403,545 | $3,119,402 | |
| PRAX | Praxis Precision Medicines, Inc. | 7,540 | $2,524,316 | |
| RLMD | Relmada Therapeutics, Inc. | 348,265 | $2,409,993 | |
| XENE | Xenon Pharmaceuticals Inc. | 33,300 | $2,009,988 | |
| SNDX | Syndax Pharmaceuticals Inc | 77,930 | $1,703,549 | |
| ANL | Adlai Nortye Group Ltd. | 113,207 | $1,301,880 | |
| OKUR | OnKure Therapeutics, Inc. | 240,963 | $1,098,791 | |
| SMMT | Summit Therapeutics Inc. | 73,300 | $1,067,981 | |
| ENGN | enGene Therapeutics Inc. | 411,065 | $711,142 | |
| NGNE | Neurogene Inc. | 22,060 | $693,787 | |
| OLMA | Olema Pharmaceuticals, Inc. | 31,476 | $393,764 | |
| CUE | Cue Biopharma, Inc. | 10,702 | $337,755 | |
| MBX | MBX Biosciences, Inc. | 6,000 | $331,200 | |
| VKTX | Viking Therapeutics, Inc. | 7,404 | $288,830 | |
| AZN | Astrazeneca PLC | 1,400 | $265,468 | |
| STOK | Stoke Therapeutics, Inc. | 7,745 | $253,416 | |
| WVE | Wave Life Sciences, Inc. | 19,048 | $110,668 | |
| QURE | uniQure N.V. | 338 | $15,568 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | 195,685 | $7,494,735 | |
| MLYS | Mineralys Therapeutics, Inc. | 69,571 | $1,884,678 | |
| REPL | Replimune Group, Inc. | 120,400 | $921,060 | |
| MAZE | Maze Therapeutics, Inc. | 30,707 | $916,603 | |
| CLYM | Climb Bio, Inc. | 130,654 | $894,979 | |
| CMPS | COMPASS Pathways plc | 158,021 | $873,856 | |
| DNLI | Denali Therapeutics Inc. | 35,286 | $677,491 | |
| UTHR | UNITED THERAPEUTICS Corp | 1,128 | $668,881 | |
| LLY | ELI LILLY & Co | 720 | $662,234 | |
| VSTM | Verastem, Inc. | 123,400 | $654,020 | |
| CNTX | Context Therapeutics Inc. | 190,785 | $499,856 | |
| NTLA | Intellia Therapeutics, Inc. | 31,500 | $403,830 | |
| EWTX | Edgewise Therapeutics, Inc. | 11,701 | $368,581 | |
| NKTR | Nektar Therapeutics | 4,300 | $309,385 | |
| SEPN | Septerna, Inc. | 11,445 | $275,023 | |
| OCUL | Ocular Therapeutix, Inc | 31,296 | $265,077 | |
| IRON | Disc Medicine, Inc. | 3,231 | $206,590 | |
| WHWK | Whitehawk Therapeutics, Inc. | 54,296 | $187,321 | |
| INBX | Inhibrx Biosciences, Inc. | 2,482 | $166,864 | |
| APGE | Apogee Therapeutics, Inc. | 1,969 | $165,730 | |
| PEPG | PepGen Inc. | 59,500 | $105,315 | |
| MGNX | Macrogenics Inc | 13,387 | $38,688 | |
| CGEM | Cullinan Therapeutics, Inc. | 1,844 | $26,203 | |
| — | 115,770 | $0 | ||
| — | 128,487 | $0 | ||
| No positions match the current search. | ||||
95 tracked positions ·
$609,560,652 total
· filing declares
114 positions · $605,916,390
· as of Jun 30, 2026
Showing 1–50
of 95 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 1,886,236 | $134,017,067 | 21.99% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 3,228,144 | $100,911,781 | 16.55% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 242,029 | $45,327,190 | 7.44% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 774,501 | $26,782,243 | 4.39% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 256,603 | $20,458,957 | 3.36% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 365,386 | $18,543,339 | 3.04% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 111,334 | $14,836,368 | 2.43% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 770,765 | $14,243,736 | 2.34% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
NEW | 110,393 | $12,923,708 | 2.12% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 433,147 | $11,902,879 | 1.95% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Added | 4,347,826 | $10,652,173 | 1.75% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 1,504,400 | $10,244,964 | 1.68% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 118,240 | $10,072,865 | 1.65% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 80,000 | $9,835,200 | 1.61% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Added | 246,606 | $8,567,092 | 1.41% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 220,126 | $7,790,259 | 1.28% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Added | 284,430 | $7,398,024 | 1.21% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 117,067 | $7,368,196 | 1.21% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 28,826 | $7,055,740 | 1.16% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 148,647 | $6,992,354 | 1.15% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 64,723 | $6,309,197 | 1.04% | |
| XNCR |
Xencor Inc
Healthcare
|
Added | 368,305 | $5,929,710 | 0.97% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 147,510 | $5,708,637 | 0.94% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 308,007 | $5,642,687 | 0.93% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 45,400 | $5,565,132 | 0.91% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Added | 1,001,373 | $5,557,619 | 0.91% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
NEW | 159,118 | $5,282,717 | 0.87% | |
| EDIT |
Editas Medicine, Inc.
Healthcare
|
NEW | 1,330,500 | $4,310,820 | 0.71% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 1,085,398 | $4,070,242 | 0.67% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Added | 610,785 | $4,037,288 | 0.66% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 178,222 | $3,334,533 | 0.55% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 86,664 | $3,224,767 | 0.53% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 11,869 | $3,165,699 | 0.52% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
NEW | 403,545 | $3,119,402 | 0.51% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
Added | 736,077 | $2,870,700 | 0.47% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 4,973 | $2,670,252 | 0.44% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 136,016 | $2,584,304 | 0.42% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
NEW | 7,540 | $2,524,316 | 0.41% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 348,265 | $2,409,993 | 0.40% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Reduced | 56,900 | $2,111,559 | 0.35% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 33,300 | $2,009,988 | 0.33% | |
| SVRA |
Savara Inc
Healthcare
|
Added | 309,103 | $1,904,074 | 0.31% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
Added | 381,169 | $1,780,059 | 0.29% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 29,800 | $1,732,274 | 0.28% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
NEW | 77,930 | $1,703,549 | 0.28% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 16,252 | $1,700,284 | 0.28% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Added | 317,600 | $1,540,360 | 0.25% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 26,800 | $1,438,356 | 0.24% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Reduced | 154,153 | $1,416,666 | 0.23% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 37,865 | $1,411,228 | 0.23% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.